Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Map3k11 | Mouse | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP3K11 mRNA | CTD | PMID:22206623 | Map3k11 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of MAP3K11 gene and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to MAP3K11 promoter] | CTD | PMID:19654925 and PMID:21212295 | Map3k11 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Map3k11 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MAP3K11 mRNA | CTD | PMID:34747641 | Map3k11 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAP3K11 mRNA | CTD | PMID:21570461 | Map3k11 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MAP3K11 mRNA | CTD | PMID:15652763 | Map3k11 | Mouse | 2,4-dinitrotoluene | affects expression | ISO | Map3k11 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of MAP3K11 mRNA | CTD | PMID:21346803 | Map3k11 | Mouse | 2,6-dinitrotoluene | affects expression | ISO | Map3k11 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of MAP3K11 mRNA | CTD | PMID:21346803 | Map3k11 | Mouse | 4,4'-sulfonyldiphenol | affects methylation | EXP | | 6480464 | bisphenol S affects the methylation of MAP3K11 gene | CTD | PMID:31683443 | Map3k11 | Mouse | 6-propyl-2-thiouracil | decreases expression | ISO | Map3k11 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of MAP3K11 mRNA | CTD | PMID:24780913 | Map3k11 | Mouse | acrolein | multiple interactions | ISO | MAP3K11 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of MAP3K11 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of MAP3K11 mRNA | CTD | PMID:32699268 | Map3k11 | Mouse | aflatoxin B1 | decreases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of MAP3K11 mRNA | CTD | PMID:27153756 | Map3k11 | Mouse | all-trans-retinoic acid | increases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of MAP3K11 mRNA | CTD | PMID:33167477 | Map3k11 | Mouse | alpha-pinene | multiple interactions | ISO | MAP3K11 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of MAP3K11 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of MAP3K11 mRNA | CTD | PMID:32699268 | Map3k11 | Mouse | antirheumatic drug | decreases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of MAP3K11 mRNA | CTD | PMID:24449571 | Map3k11 | Mouse | aristolochic acid A | increases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of MAP3K11 mRNA | CTD | PMID:33212167 | Map3k11 | Mouse | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to MAP3K11 promoter] | CTD | PMID:19654925 | Map3k11 | Mouse | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MAP3K11 mRNA | CTD | PMID:22228805 | Map3k11 | Mouse | benzo[a]pyrene | decreases expression | ISO | Map3k11 (Rattus norvegicus) | 6480464 | Benzo(a)pyrene results in decreased expression of MAP3K11 mRNA | CTD | PMID:21839799 | Map3k11 | Mouse | bisphenol A | affects expression | ISO | Map3k11 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of MAP3K11 mRNA | CTD | PMID:25181051 | Map3k11 | Mouse | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MAP3K11 mRNA | CTD | PMID:32156529 | Map3k11 | Mouse | bisphenol A | decreases expression | ISO | Map3k11 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of MAP3K11 mRNA | CTD | PMID:34947998 | Map3k11 | Mouse | caffeine | decreases phosphorylation | ISO | MAP3K11 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of MAP3K11 protein | CTD | PMID:35688186 | Map3k11 | Mouse | copper atom | multiple interactions | ISO | MAP3K11 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in decreased expression of MAP3K11 mRNA | CTD | PMID:30911355 | Map3k11 | Mouse | copper(0) | multiple interactions | ISO | MAP3K11 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in decreased expression of MAP3K11 mRNA | CTD | PMID:30911355 | Map3k11 | Mouse | copper(II) chloride | increases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | cupric chloride results in increased expression of MAP3K11 mRNA | CTD | PMID:38568856 | Map3k11 | Mouse | copper(II) sulfate | decreases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of MAP3K11 mRNA | CTD | PMID:19549813 | Map3k11 | Mouse | crocidolite asbestos | affects expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Asbestos and Crocidolite affects the expression of MAP3K11 mRNA | CTD | PMID:17331233 | Map3k11 | Mouse | crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos and Crocidolite results in increased expression of MAP3K11 mRNA | CTD | PMID:29279043 | Map3k11 | Mouse | Cuprizon | increases expression | ISO | Map3k11 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of MAP3K11 mRNA | CTD | PMID:26577399 | Map3k11 | Mouse | cyclosporin A | decreases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of MAP3K11 mRNA | CTD | PMID:20106945 and PMID:25562108 | Map3k11 | Mouse | diazinon | increases methylation | ISO | MAP3K11 (Homo sapiens) | 6480464 | Diazinon results in increased methylation of MAP3K11 gene | CTD | PMID:22964155 | Map3k11 | Mouse | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of MAP3K11 mRNA | CTD | PMID:21266533 | Map3k11 | Mouse | doxorubicin | decreases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of MAP3K11 mRNA | CTD | PMID:29803840 | Map3k11 | Mouse | ethanol | affects expression | EXP | | 6480464 | Ethanol affects the expression of MAP3K11 mRNA | CTD | PMID:30319688 | Map3k11 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP3K11 mRNA | CTD | PMID:22206623 | Map3k11 | Mouse | FR900359 | increases phosphorylation | ISO | MAP3K11 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of MAP3K11 protein | CTD | PMID:37730182 | Map3k11 | Mouse | fulvestrant | increases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | fulvestrant results in increased expression of MAP3K11 mRNA | CTD | PMID:12154049 | Map3k11 | Mouse | furan | increases methylation | ISO | Map3k11 (Rattus norvegicus) | 6480464 | furan results in increased methylation of MAP3K11 gene | CTD | PMID:22079235 | Map3k11 | Mouse | lipopolysaccharide | increases phosphorylation | ISO | MAP3K11 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased phosphorylation of MAP3K11 protein | CTD | PMID:17698565 | Map3k11 | Mouse | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of MAP3K11 gene | CTD | PMID:21212295 | Map3k11 | Mouse | manganese(II) chloride | increases phosphorylation | ISO | Map3k11 (Rattus norvegicus) | 6480464 | manganese chloride results in increased phosphorylation of MAP3K11 protein | CTD | PMID:15342272 | Map3k11 | Mouse | NSC 23766 | multiple interactions | ISO | MAP3K11 (Homo sapiens) | 6480464 | NSC 23766 inhibits the reaction [Zinc Oxide results in increased expression of MAP3K11 protein] | CTD | PMID:22166487 | Map3k11 | Mouse | ozone | multiple interactions | ISO | MAP3K11 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of MAP3K11 mRNA more ... | CTD | PMID:32699268 and PMID:35430440 | Map3k11 | Mouse | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAP3K11 mRNA | CTD | PMID:34911549 | Map3k11 | Mouse | perfluorohexanesulfonic acid | decreases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in decreased expression of MAP3K11 mRNA | CTD | PMID:37995155 | Map3k11 | Mouse | perfluorononanoic acid | decreases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of MAP3K11 mRNA | CTD | PMID:38568856 | Map3k11 | Mouse | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of MAP3K11 mRNA | CTD | PMID:36331819 | Map3k11 | Mouse | poly(I:C) | increases phosphorylation | ISO | MAP3K11 (Homo sapiens) | 6480464 | Poly I-C results in increased phosphorylation of MAP3K11 protein | CTD | PMID:17698565 | Map3k11 | Mouse | raloxifene | increases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Raloxifene Hydrochloride results in increased expression of MAP3K11 mRNA | CTD | PMID:12154049 | Map3k11 | Mouse | selenomethionine | affects expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Selenomethionine affects the expression of MAP3K11 mRNA | CTD | PMID:17222674 | Map3k11 | Mouse | sodium arsenite | increases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of MAP3K11 mRNA | CTD | PMID:38568856 | Map3k11 | Mouse | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of MAP3K11 mRNA | CTD | PMID:36209798 | Map3k11 | Mouse | sulfates | affects methylation | ISO | MAP3K11 (Homo sapiens) | 6480464 | Sulfates affects the methylation of MAP3K11 promoter | CTD | PMID:25395096 | Map3k11 | Mouse | thimerosal | decreases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of MAP3K11 mRNA | CTD | PMID:27188386 | Map3k11 | Mouse | thioacetamide | increases expression | ISO | Map3k11 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of MAP3K11 mRNA | CTD | PMID:34492290 | Map3k11 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of MAP3K11 gene | CTD | PMID:35295148 | Map3k11 | Mouse | triphenyl phosphate | affects expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of MAP3K11 mRNA | CTD | PMID:37042841 | Map3k11 | Mouse | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of MAP3K11 mRNA | CTD | PMID:30912803 | Map3k11 | Mouse | urethane | increases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Urethane results in increased expression of MAP3K11 mRNA | CTD | PMID:28818685 | Map3k11 | Mouse | valproic acid | increases methylation | ISO | MAP3K11 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of MAP3K11 gene | CTD | PMID:29154799 | Map3k11 | Mouse | valproic acid | decreases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of MAP3K11 mRNA | CTD | PMID:28001369 | Map3k11 | Mouse | valproic acid | affects expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MAP3K11 mRNA | CTD | PMID:25979313 | Map3k11 | Mouse | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of MAP3K11 mRNA | CTD | PMID:17963808 | Map3k11 | Mouse | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of MAP3K11 mRNA | CTD | PMID:21427059 | Map3k11 | Mouse | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of MAP3K11 mRNA | CTD | PMID:21427059 | Map3k11 | Mouse | zinc oxide | multiple interactions | ISO | MAP3K11 (Homo sapiens) | 6480464 | NSC 23766 inhibits the reaction [Zinc Oxide results in increased expression of MAP3K11 protein] | CTD | PMID:22166487 | Map3k11 | Mouse | zinc oxide | increases expression | ISO | MAP3K11 (Homo sapiens) | 6480464 | Zinc Oxide results in increased expression of MAP3K11 protein | CTD | PMID:22166487 | |